Allianz Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Allianz Asset Management's IDXX Position: Q1 2026 in Review
Allianz Asset Management reduced its Idexx Laboratories (IDXX) stake by 4% in Q1 2026, selling an estimated $5.55M and leaving 207,403 shares worth $117M. The position accounts for 0.12% of the portfolio, ranked #165.
Allianz Asset Management first reported a position in IDXX in Q4 2013 and has held it in 42 quarters since. The position peaked at $199M in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Allianz Asset Management held 207,403 shares of Idexx Laboratories worth $117M as of Q1 2026.
- Allianz Asset Management sold 8,654 Idexx Laboratories shares in Q1 2026, an estimated $5.55M.
- Idexx Laboratories made up 0.12% of Allianz Asset Management's portfolio in Q1 2026, its #165 holding.
- Allianz Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 42 quarters since.
- Allianz Asset Management's Idexx Laboratories position peaked at $199M in Q2 2021.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.